From a prognostic point of view, AFAP1-AS1 levels have been associated with tumor depth, tumor differentiation, TNM stage and other determinants of patients’ survival, thus could be used as markers for prediction of clinical outcomes of patients with a variety of malignant conditions. This evidence concerns the gene AFAP1 and neoplasm.